Glenmark Pharmaceuticals Limited
NSE: GLENMARK | Information Technology
Market Fundamentals
Stock Intelligence & News
Glenmark Pharmaceuticals Ltd (532296)
Glenmark Pharmaceuticals receives Establishment Inspection Report (EIS) from U.S. FDA for its Goa facility with VAI classification
Read Full Analysis →Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 23, 2026, titled "Glenmark Pharmaceuticals receives Establishment Inspection Report (EIR) from U.S. FDA for its Goa facility with VAI classification". |SUBJECT: Press Release
Read Full Analysis →Glenmark Pharmaceuticals Ltd (532296)
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Schedule of Analyst/ Institutional Investor Meetings
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Stocks to watch, Sept 15: HDFC Bank, BSE, broking firms, HCL Tech, Deccan Gold Mines, CESC, Glenmark, BHEL, Patel Airtemp, Lenskart, Heidelberg, AU Small Fiance Bank, Gland Pharma
Key developments this week include HDFC Bank’s leadership transition, regulatory changes for brokerages, BHEL’s significant investments, strategic partnerships in technology and mining, and major acquisitions and production milestones from Lenskart, Gland Pharma, and Elin Electronics.
Read Full Analysis →Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 11, 2026, titled "Glenmark Expands Global Respiratory Innovation Footprint with RYALTRIS® Launch in Brazil ". |SUBJECT: Press Release
Read Full Analysis →Glenmark Pharmaceuticals Ltd (532296)
Glenmark expands Global Respiratory Innovation Footprint with RYALTRIS launch in Brazil
Read Full Analysis →Glenmark Pharmaceuticals Ltd (532296)
Please find enclosed rating rationale issued by India Ratings and Research
Read Full Analysis →Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited has informed the Exchange about Credit Rating |SUBJECT: Credit Rating
Read Full Analysis →10 midcap stocks with over 150% profit growth in Q1FY27
Data from StockEdge shows top 10 NSE midcap stocks that reported over 150% YoY net profit growth in the Q1FY27 June quarter. Glenmark Pharmaceuticals, Bharat Dynamics, and Poonawalla Fincorp led the surge with strong financial performance compared to the same period in the previous fiscal year.
Read Full Analysis →Dividend Stocks To Watch: Coal India, NTP, ONGC, Shipping Corp, Gail, Glenmark Pharma, Mastek And 82 Others; Check Full List
To be eligible for these payouts, investors must be mindful of the ex-dividend date, which is the day the share price adjusts to reflect the upcoming dividend.
Read Full Analysis →Get instant alerts when GLENMARK breaks news
Join investors who track Glenmark Pharmaceuticals Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for GLENMARK?
GLENMARK is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Glenmark Pharmaceuticals Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding GLENMARK to your custom watchlist.